| Bioactivity | Neurokinin antagonist 1 is a Neurokinin antagonist extracted from patent WO1998045262A1. |
| Target | Neurokinin |
| Invitro | The invention in the patent WO1998045262A1 refers to antagonists of the interaction between the P substance and the NK-1 receptor, the process for their preparation, and their use in pharmaceutical compositions which may be used in the treatment of pathological forms in which the P substance receptor is involved, and in particular in the treatment of the inflammation of airways, such as asthma and rhinitis, and in the treatment of emesis[1]. |
| Name | Neurokinin antagonist 1 |
| CAS | 214487-45-3 |
| Formula | C38H40N4O3 |
| Molar Mass | 600.75 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Sisto Alessandro, et al. Pseudo-peptide compounds as antagonists of neurokinines. WO1998045262A1. |